GB202313798D0 - Methods and compositions for treating or preventing a disease or a condition - Google Patents

Methods and compositions for treating or preventing a disease or a condition

Info

Publication number
GB202313798D0
GB202313798D0 GBGB2313798.7A GB202313798A GB202313798D0 GB 202313798 D0 GB202313798 D0 GB 202313798D0 GB 202313798 A GB202313798 A GB 202313798A GB 202313798 D0 GB202313798 D0 GB 202313798D0
Authority
GB
United Kingdom
Prior art keywords
disease
compositions
treating
preventing
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2313798.7A
Other versions
GB2619220A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Libi Pharm Ltd
Original Assignee
Libi Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libi Pharm Ltd filed Critical Libi Pharm Ltd
Publication of GB202313798D0 publication Critical patent/GB202313798D0/en
Publication of GB2619220A publication Critical patent/GB2619220A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
GB2313798.7A 2021-03-25 2022-03-25 Methods and compositions for treating or preventing a disease or a condition Pending GB2619220A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163165793P 2021-03-25 2021-03-25
PCT/IL2022/050334 WO2022201168A1 (en) 2021-03-25 2022-03-25 Methods and compositions for treating or preventing a disease or a condition

Publications (2)

Publication Number Publication Date
GB202313798D0 true GB202313798D0 (en) 2023-10-25
GB2619220A GB2619220A (en) 2023-11-29

Family

ID=81386495

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2313798.7A Pending GB2619220A (en) 2021-03-25 2022-03-25 Methods and compositions for treating or preventing a disease or a condition

Country Status (2)

Country Link
GB (1) GB2619220A (en)
WO (1) WO2022201168A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707421B2 (en) * 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
CA3013835A1 (en) * 2016-02-16 2017-08-24 Atp Institute Pty Ltd Formulation and method of use

Also Published As

Publication number Publication date
GB2619220A (en) 2023-11-29
WO2022201168A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
IL290920A (en) Methods and compositions for treating a disease or disorder
ZA202207394B (en) Compositions and methods for treating hemoglobinopathies
SG10202002898RA (en) A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease
EP3609525A4 (en) Compositions and methods for treating or preventing gut permeability-related disorders
IL285886A (en) Compositions and methods for treating laminopathies
ZA202210078B (en) Compositions and methods for treating and preventing non-malignant respiratory disease
EP3927710A4 (en) Compositions and methods for treating or preventing alzheimer's disease
IL292221A (en) Compositions and methods for treating liver disease
SG11202102442WA (en) Methods and compositions for preventing and treating atherosclerosis and related diseases
EP3804759A4 (en) Method for treating and/or preventing regnase-1-related disease
IL288440A (en) Compositions and methods for treating retinopathy
IL304273A (en) Compositions and methods for treating fabry disease
EP4106748A4 (en) Compositions and methods for treating renal injury
IL304771A (en) Compositions and methods for treating disease associated with dux4 overexpression
PL3810128T3 (en) Compositions for treating and/or preventing protein-aggregation diseases
GB202313798D0 (en) Methods and compositions for treating or preventing a disease or a condition
ZA202107235B (en) Compositions and methods for treating ocular disease
IL286083A (en) Compositions and methods for treating huntington’s disease
IL285796A (en) Methods and compositions for treating
EP4058043A4 (en) Compositions and methods for treating or preventing crohn's disease
EP4103177A4 (en) Compositions and methods for treating and/or preventing ocular disorders
SG11202109032SA (en) Compounds for treating and preventing net associated complications
EP4037696A4 (en) Compositions and methods for treating alzheimer's disease
EP4025199A4 (en) Compositions and methods for treating alzheimers disease
EP3607949A4 (en) Composition for preventing and treating muscular disease